Close

DURECT Corp (DRRX) Announces U.S. FDA Approval of POSIMIR For Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. LVS
2. TSM
3. SPY
4. NFLX
5. CSX
6. UAL
7. TSLA
8. ALK
9. EFX
10. INFY


Go back to DURECT Corp (DRRX) Announces U.S. FDA Approval of POSIMIR For Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression
Durect Corp (NASDAQ: DRRX) Delayed: 0.91 +0.03 (3.41%)
Previous Close $0.88    52 Week High $2.70 
Open $0.88    52 Week Low $0.99 
Day High $0.94    P/E N/A 
Day Low $0.86    EPS $-0.22 
Volume 115,711